1. Incidental findings of borderline ovarian tumor or ovarian cancer – real-world data on surgical and oncological outcomes
- Author
-
Carmen Joder, Celine Smaadahl-Wey, Lara Zumwald, Flurina Saner, Claudia Rauh, Seline Hofer, Julian Wampfler, Saskia Schlootz, Tilman Rau, Lucine Christe, Wiebke Solass, Sara Imboden, Michael David Mueller, and Franziska Siegenthaler
- Subjects
ovarian cancer ,borderline ovarian tumor ,centralized care ,surgical cytoreduction ,surgical morbidity ,oncological outcome ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
IntroductionCentralization of ovarian cancer treatment is associated with higher rates of optimal surgery and longer survival. However, preoperative diagnosis of ovarian cancer is challenging and some diagnoses are made incidentally after surgery. This study investigated the surgical and oncological outcomes of patients with incidental findings of borderline ovarian tumors or ovarian cancer who were centralized postoperatively and treated with a two-stage surgical procedure, and compared these with those of patients with adnexal masses of suspected malignancy who were offered a single-stage surgical procedure with intraoperative frozen section in a tertiary hospital.MethodsA database of 390 patients with adnexal masses and surgical treatment at the Bern University Hospital, Switzerland was retrospectively reviewed to identify patients with borderline ovarian tumors or ovarian cancer between 2010 and 2020.ResultsAmong 390 patients with adnexal masses, 223 were diagnosed with a borderline ovarian tumor or ovarian cancer. Compared with patients with suspected malignancy and a centralized single-stage surgical procedure, patients with an incidental postoperative malignancy diagnosis and a two-stage surgical procedure underwent more surgical interventions (1.3 vs. 2.1 p
- Published
- 2024
- Full Text
- View/download PDF